Clinical trials: De Novo Lipogenesis (DNL)
PD Effects of GS-0976 (NDI-010976) on Fractional DNL
Study to Evaluate the Pharmacodynamic Effects of a Single Oral Dose of GS-0976 (NDI-010976) in Healthy Adult Subjects
The primary objective of this study is to assess the pharmacodynamic (PD) effects of GS-0976 (NDI-010976) on fractional de novo lipogenesis (DNL) following a single oral dose administration in overweight and/or obese, but…
- Trial name
- NCT02876796
- Testing
- GS-0976, 1-13C acetate, Fructose solution
- Where
- United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Gilead Sciences